questionText: To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number and proportion of patients who, having developed impulse control disorders while taking dopamine agonists and attempted withdrawal, subsequently return to their previous dopamine agonist dose or restart a dopamine agonist where withdrawal symptoms were recorded as the reason.
answerText: The information requested on dopamine agonists is not held centrally nor held in the format requested and could only be obtained at disproportionate cost.Dopamine agonists encompass a range of medicines authorised for the management of Parkinson’s disease...
heading: Drugs: Side Effects